Venus Concept Retained Earnings (Accumulated Deficit) 2016-2024 | VERO

Venus Concept retained earnings (accumulated deficit) from 2016 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.

Venus Concept Retained Earnings (Accumulated Deficit) 2016-2024 | VERO

Venus Concept retained earnings (accumulated deficit) from 2016 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$209.2B
Intuitive Surgical (ISRG)$190.8B
Alcon (ALC)$45.5B
IQVIA Holdings (IQV)$39.4B
Edwards Lifesciences (EW)$39.3B
IDEXX Laboratories (IDXX)$35.8B
DexCom (DXCM)$27.5B
Waters (WAT)$22.6B
SONOVA HOLDING (SONVY)$22.1B
STERIS (STE)$21.9B
Hologic (HOLX)$18.4B
Sysmex ADR (SSMXY)$12.9B
Fresenius Medical Care AG KGaA (FMS)$12.6B
Globus Medical (GMED)$11.1B
Penumbra (PEN)$9.3B
Teleflex (TFX)$9.2B
Masimo (MASI)$8.7B
Glaukos (GKOS)$7.9B
PROCEPT BioRobotics (PRCT)$5.1B
Integer Holdings (ITGR)$4.7B
Inari Medical (NARI)$3.1B
Veracyte (VCYT)$3B
TransMedics (TMDX)$3B
LivaNova (LIVN)$2.8B
Nihon Kohden (NHNKY)$2.6B
Elekta AB (EKTAY)$2.3B
Tandem Diabetes Care (TNDM)$2.1B
Integra LifeSciences Holdings (IART)$2B
RxSight (RXST)$1.9B
Alphatec Holdings (ATEC)$1.4B